{
    "2021-01-27": [
        [
            {
                "time": "",
                "original_text": "生物医药行业深度报告：长期看好港股医药优质细分领域龙头",
                "features": {
                    "keywords": [
                        "生物医药",
                        "港股",
                        "医药",
                        "优质细分领域",
                        "龙头"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【中金医药】2020年报业绩预览 - 中金医药周报（勘误）",
                "features": {
                    "keywords": [
                        "中金医药",
                        "2020年报",
                        "业绩预览"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "大行评级|美银证券：上调康龙化成(3759.HK)目标价至201港元评级“买入”",
                "features": {
                    "keywords": [
                        "美银证券",
                        "康龙化成",
                        "目标价",
                        "买入"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "美银证券：重申康龙化成(03759)“买入”评级 目标价上调19.6%至201港元",
                "features": {
                    "keywords": [
                        "美银证券",
                        "康龙化成",
                        "买入",
                        "目标价上调"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(300759)：20年收入持续提速 实验室业务拉动整体毛利率提升",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "收入提速",
                        "实验室业务",
                        "毛利率提升"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(300759)：略超预期 看好新产能 平台化加速节奏",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "略超预期",
                        "新产能",
                        "平台化加速"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "高盛料康龙化成(03759-HK)实验室及CMC服务持续强劲增长目标价升至204.3港元",
                "features": {
                    "keywords": [
                        "高盛",
                        "康龙化成",
                        "实验室",
                        "CMC服务",
                        "强劲增长",
                        "目标价升"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "高盛上调康龙化成目标价至204.3港元，维持买入评级",
                "features": {
                    "keywords": [
                        "高盛",
                        "康龙化成",
                        "目标价",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上调评级至买入策略选股（1月27日）",
                "features": {
                    "keywords": [
                        "上调评级",
                        "买入",
                        "策略选股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "南向资金高比例持有港股名单",
                "features": {
                    "keywords": [
                        "南向资金",
                        "高比例持有",
                        "港股名单"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(300759)：业绩预告全年高增 看好盈利能力提升下加速成长",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "业绩预告",
                        "全年高增",
                        "盈利能力提升",
                        "加速成长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|点评】康龙化成：略超预期，看好新产能、平台化加速节奏",
                "features": {
                    "keywords": [
                        "浙商医药",
                        "康龙化成",
                        "略超预期",
                        "新产能",
                        "平台化加速"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}